Correlation of p53, MDM2 and p14ARF protein expression in human esophageal squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 11, 2009, Pages 1577-1582

  Cheng, Tzu Hao ^a   Hsu, Po Kuei ^b   Li, Anna Fen Yau ^b   Hung, I Chun ^b   Huang, Min Hsiung ^b   Hsu, Han Shui ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Esophageal cancer; Immunohistochemistry; MDM2; P14ARF; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN MDM2; PROTEIN P53; MDM2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; CHEMISTRY; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349569040     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0605-5     Document Type: Article

References (33)

1. A Agrawal J Yang RF Murphy DK Agrawal 2006 Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer Exp Mol Pathol 81 115 122 10.1016/j.yexmp.2006.07.001 16919268 10.1016/j.yexmp.2006.07.001 (Pubitemid 44717514)
2. S Arora R Mathew M Mathur TK Chattopadhayay R Ralhan 2001 Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status Pathol Oncol Res 7 203 208 11692147 (Pubitemid 33716856)
3. C Capoulade B Bressac-de Paillerets I Lefrere M Ronsin J Feunteun T Tursz J Wiels 1998 Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells Oncogene 16 1603 1610 10.1038/sj.onc.1201702 9569028 10.1038/sj.onc.1201702
4. C Cordon-Cardo E Latres M Drobnjak MR Oliva D Pollack JM Woodruff V Marechal J Chen MF Brennan AJ Levine 1994 Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas Cancer Res 54 794 799 8306343 (Pubitemid 24068339)
5. B Culjkovic I Topisirovic L Skrabanek M Ruiz-Gutierrez KL Borden 2006 eIF4E is a central node of an RNA regulon that governs cellular proliferation J Cell Biol 175 415 426 10.1083/jcb.200607020 17074885 10.1083/jcb.200607020 (Pubitemid 44708066)
6. HJ Fahn LS Wang BS Huang MH Huang KY Chien 1994 Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus Ann Thorac Surg 57 677 681 8147640
7. S Gallagher RF Kefford H Rizos 2005 Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis Cell Cycle 4 465 472 15701968
8. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging manual. Springer, New York
9. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 10.1038/sj.onc.1208615 15838523 10.1038/sj.onc. 1208615 (Pubitemid 40638098)
10. M Higashiyama O Doi K Kodama H Yokouchi T Kasugai S Ishiguro K Takami T Nakayama I Nishisho 1997 MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation Br J Cancer 75 1302 1308 9155050
11. R Honda H Tanaka H Yasuda 1997 Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett 420 25 27 10.1016/S0014-5793(97)01480-4 9450543 10.1016/S0014-5793(97)01480-4 (Pubitemid 28037193)
12. HS Hsu YC Wang RC Tseng JW Chang JT Chen CM Shih CY Chen 2004 5cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer Clin Cancer Res 10 4734 4741 10.1158/1078-0432.CCR- 03-0704 15269146 10.1158/1078-0432.CCR-03-0704 (Pubitemid 38955524)
13. G Ikeda S Isaji B Chandra M Watanabe Y Kawarada 1999 Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus Cancer 86 1396 1405 10.1002/(SICI)1097-0142(19991015)86:8<1396::AID- CNCR3>3.0.CO;2-H 10526265 10.1002/(SICI)1097-0142(19991015)86:8<1396::AID- CNCR3>3.0.CO;2-H (Pubitemid 29489770)
14. M Ikeguchi T Ueda K Fukuda K Yamaguchi S Tsujitani N Kaibara 2002 Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment Am J Clin Oncol 25 454 459 10.1097/00000421-200210000-00006 12393983 10.1097/00000421-200210000-00006 (Pubitemid 35154948)
15. JE Landers SL Cassel DL George 1997 Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein Cancer Res 57 3562 3568 9270029
16. FS Leach T Tokino P Meltzer M Burrell JD Oliner S Smith DE Hill D Sidransky KW Kinzler B Vogelstein 1993 p53 Mutation and MDM2 amplification in human soft tissue sarcomas Cancer Res 53 2231 2234 8387391
17. P Lianes I Orlow ZF Zhang MR Oliva AS Sarkis VE Reuter C Cordon-Cardo 1994 Altered patterns of MDM2 and TP53 expression in human bladder cancer J Natl Cancer Inst 86 1325 1330 10.1093/jnci/86.17.1325 8064890 10.1093/jnci/86.17. 1325 (Pubitemid 24276794)
18. AM Mandard P Hainaut M Hollstein 2000 Genetic steps in the development of squamous cell carcinoma of the esophagus Mutat Res 462 335 342 10.1016/S1383-5742(00)00019-3 10767643 10.1016/S1383-5742(00)00019-3 (Pubitemid 30190239)
19. M Matsumoto M Furihata A Kurabayashi K Araki S Sasaguri Y Ohtsuki 2003 Association between inducible nitric oxide synthase expression and p53 status in human esophageal squamous cell carcinoma Oncology 64 90 96 10.1159/000066519 12457036 10.1159/000066519 (Pubitemid 35477959)
20. J Momand GP Zambetti DC Olson D George AJ Levine 1992 The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1237 1245 10.1016/0092-8674(92)90644-R 1535557 10.1016/0092-8674(92)90644-R
21. CO Nathan K Sanders FW Abreo R Nassar J Glass 2000 Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications Cancer Res 60 3599 3604 10910074
22. V Robert P Michel JM Flaman A Chiron C Martin F Charbonnier B Paillot T Frebourg 2000 High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis Carcinogenesis 21 563 565 10.1093/carcin/21.4.563 10753186 10.1093/carcin/21.4. 563
23. AR Rosa CC Schirmer RR Gurski L Meurer MI Edelweiss CD Kruel 2003 Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus Dis Esophagus 16 112 118 10.1046/j.1442-2050.2003.00309.x 12823209 10.1046/j.1442-2050.2003.00309.x (Pubitemid 36992384)
24. H Saito S Tsujitani S Oka M Ikeguchi M Maeta N Kaibara 2002 The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation Ann Surg Oncol 9 450 456 10.1007/BF02557267 12052755 10.1007/BF02557267 (Pubitemid 34625804)
25. I Shibagaki H Tanaka Y Shimada T Wagata M Ikenaga M Imamura K Ishizaki 1995 p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma Clin Cancer Res 1 769 773 9816044
26. J Smeds P Berggren X Ma Z Xu K Hemminki R Kumar 2002 Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation Carcinogenesis 23 645 655 10.1093/carcin/23.4.645 11960918 10.1093/carcin/23.4. 645
27. FJ Stott S Bates MC James BB McConnell M Starborg S Brookes I Palmero K Ryan E Hara KH Vousden G Peters 1998 The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2 EMBO J 17 5001 5014 10.1093/emboj/17.17.5001 9724636 10.1093/emboj/17.17. 5001 (Pubitemid 28408466)
28. A Volant JB Nousbaum MA Giroux I Roue-Quintin JP Metges C Ferec H Gouerou M Robaszkiewicz 1995 p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions J Clin Pathol 48 531 534 10.1136/jcp.48.6.531 7665695 10.1136/jcp.48.6.531
29. YC Wang RK Lin YH Tan JT Chen CY Chen 2005 Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer J Clin Oncol 23 154 164 10.1200/JCO.2005.03.139 15625370 10.1200/JCO.2005.03.139 (Pubitemid 41702634)
30. JD Weber LJ Taylor MF Roussel CJ Sherr D Bar-Sagi 1999 Nucleolar Arf sequesters Mdm2 and activates p53 Nat Cell Biol 1 20 26 10.1038/8991 10559859 10.1038/8991
31. EP Xing Y Nie Y Song GY Yang YC Cai LD Wang CS Yang 1999 Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma Clin Cancer Res 5 2704 2713 10537333
32. Q Xue T Sano K Kashiwabara T Oyama T Nakajima 2001 Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung Jpn J Cancer Res 92 285 292 11267938
33. N Zhu L Gu HW Findley M Zhou 2005 Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53 Biochem Biophys Res Commun 335 1272 1279 10.1016/j.bbrc.2005.08.026 16112647 10.1016/j.bbrc.2005.08.026 (Pubitemid 41215554)